Definitions & Distinction - Speedy Slowdown Showdown
| Feature | Tolerance | Tachyphylaxis |
|---|---|---|
| Onset | Gradual (days-weeks) | Rapid (mins-hrs) |
| Mechanism | PK/PD changes (receptor ↓) | Receptor desens., mediator depletion |
| Dose Effect | ↑ Dose may restore effect | ↑ Dose ineffective |
| Recovery | Slow (on withdrawal) | Rapid (drug holiday) |
| Examples | Opioids, BZDs, alcohol | Ephedrine, nitrates (IV) |
oka
Mechanisms of Tolerance - The Body's Adaptation
- Pharmacokinetic (Dispositional) Tolerance: Altered drug ADME.
- ↑ Metabolism: e.g., CYP450 enzyme induction (barbiturates, rifampicin).
- ↓ Absorption or ↑ excretion.
- Result: ↓ plasma drug concentration, ↓ therapeutic effect.
- Pharmacodynamic (Cellular) Tolerance: Altered drug-target interaction.
- Receptor Changes:
- Downregulation: ↓ receptor number (e.g., opioids, β-agonists).
- Desensitization: ↓ receptor affinity/coupling (e.g., GPCRs).
- Post-Receptor Changes: Altered intracellular signaling.
- Physiological (Counter-regulatory) Adaptation: Body initiates opposing effects.
- E.g., Na⁺/water retention with diuretics.
- Receptor Changes:
⭐ Pharmacokinetic (dispositional) tolerance, often due to CYP450 enzyme induction by drugs like barbiturates or rifampicin, leads to reduced drug efficacy due to lower plasma concentrations.
Mechanisms of Tachyphylaxis - The Flash Fade‑Out
Tachyphylaxis signifies a rapid, acute decrease in drug responsiveness after repeated administration. Key mechanisms include:
- Depletion of Mediators: Exhaustion of endogenous substances (e.g., norepinephrine by tyramine, ephedrine).
- Receptor Alterations:
- Phosphorylation: Alters receptor sensitivity.
- Internalization/Downregulation: Receptors removed from the cell surface.
- Conformational Changes: Receptor structure modified, impairing drug interaction.
⭐ Tachyphylaxis to indirectly acting sympathomimetics (e.g., ephedrine, tyramine) is commonly due to depletion of vesicular norepinephrine stores.
Clinical Examples & Management - When Drugs Lose Punch
| Drug Class/Example | Phenomenon (Tolerance/Tachyphylaxis) | Key Clinical Implication/Management |
|---|---|---|
| Organic Nitrates (e.g., Nitroglycerin) | Tachyphylaxis (Rapid) | Angina; nitrate-free interval (8-12 hours) needed. |
| Opioids (e.g., Morphine) | Tolerance (Pharmacodynamic) | Chronic pain; dose escalation; opioid rotation. |
| Beta-2 Agonists (e.g., Salbutamol) | Tolerance (Receptor downregulation) | Asthma; ↓ effect with frequent use; step-up therapy (e.g., add ICS). |
| Benzodiazepines (e.g., Diazepam) | Tolerance (Pharmacodynamic) | Anxiety/insomnia; ↓ efficacy with long-term use; taper dose. |
| Indirect Sympathomimetics (e.g., Ephedrine) | Tachyphylaxis (NT depletion) | Decongestants; rebound congestion (rhinitis medicamentosa); effect ↓ rapidly. |
High‑Yield Points - ⚡ Biggest Takeaways
- Tolerance: Gradual ↓ drug responsiveness with chronic use, requiring dose escalation.
- Tachyphylaxis: Rapidly diminishing response to a drug after acute, repeated dosing.
- Pharmacodynamic tolerance: Often involves receptor downregulation or desensitization.
- Pharmacokinetic tolerance: Typically due to ↑ drug metabolism (e.g., enzyme induction).
- Cross-tolerance: Tolerance to one drug extends to pharmacologically similar drugs (e.g., opioids).
- Nitrates exhibit tolerance to antianginal effects and tachyphylaxis to headache.
- Tachyphylaxis is common with indirectly acting sympathomimetics (e.g., ephedrine).
Unlock the full lesson and continue reading
Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more
